Skip to main content

Advertisement

Log in

Sentinel node biopsy in papillary thyroid cancer—what is the potential?

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Purpose

Sentinel node biopsy (SNB) may identify lymph node metastases in patients with papillary thyroid cancer (PTC), enabling selective application of central node dissection (CND). The aim of this study was to assess the feasibility of implementing SNB in patients undergoing thyroidectomy for a cytologically indeterminate/suspicious/malignant thyroid nodule and to determine the potential improvement in clinical outcomes and the costs associated with the SNB technique.

Methods

The treatment strategies and clinical and pathological outcomes of two retrospective cohorts of patients who underwent preoperative thyroid FNA over a 5-year period in two different centres were studied. The potential for implementing the SNB technique and the benefits and costs associated with implementation were estimated.

Results

In centre 1, in 819 adult patients who had thyroid fine-needle aspiration cytology, the final cytology was indeterminate, suspicious and diagnostic of malignancy in 113, 29 and 28 patients, respectively. One hundred eight patients were ‘suitable’ for SNB. Twenty-three of these patients had PTC, six of whom underwent CND. Of these six patients, node metastasis was absent in five—the cohort in whom prophylactic CND may have been avoided consequent to a negative ‘sentinel node’ biopsy. Morbidity attributable to CND may have been avoided in up to four patients over a 5-year period. Costs associated with implementation of SNB outweighed any potential savings.

Analysis of 491 patients in centre 2 confirmed that the benefit of SNB in PTC was similarly limited; morbidity attributable to CND may have been avoided in up to seven patients over a 5-year period.

Conclusions

Even under ideal conditions (assuming 100 % node identification rate and 0 % false negative rate), the potential short- to medium-term benefit of sentinel node biopsy in patients with thyroid cancer in centres implementing a policy of selective or routine prophylactic CND is low.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Chen SL, Iddings DM, Scheri RP, Bilchik AJ (2006) Lymphatic mapping and sentinel node analysis: current concepts and applications. CA Cancer J Clin 56(5):292–309, quiz 316–297

    Article  PubMed  Google Scholar 

  2. Chisholm EJ, Kulinskaya E, Tolley NS (2009) Systematic review and meta-analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone. Laryngoscope 119(6):1135–1139. doi:10.1002/lary.20236

    Article  PubMed  Google Scholar 

  3. Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L (2006) Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140(6):1000–1005, discussion 1005–1007

    Article  PubMed  Google Scholar 

  4. Pereira JA, Jimeno J, Miquel J, Iglesias M, Munne A, Sancho JJ, Sitges-Serra A (2005) Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 138(6):1095–1100, discussion 1100–1091

    Article  PubMed  Google Scholar 

  5. Rosenbaum MA, McHenry CR (2009) Central neck dissection for papillary thyroid cancer. Arch Otolaryngol Head Neck Surg 135(11):1092–1097. doi:10.1001/archoto.2009.158

    Article  PubMed  Google Scholar 

  6. Zetoune T, Keutgen X, Buitrago D, Aldailami H, Shao H, Mazumdar M, Fahey TJ 3rd, Zarnegar R (2010) Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis. Ann Surg Oncol 17(12):3287–3293. doi:10.1245/s10434-010-1137-6

    Article  PubMed  Google Scholar 

  7. Balasubramanian SP, Harrison BJ (2011) Systematic review and meta-analysis of sentinel node biopsy in thyroid cancer. Br J Surg 98(3):334–344. doi:10.1002/bjs.7425

    Article  CAS  PubMed  Google Scholar 

  8. Huang O, Wu W, Wang O, You J, Li Q, Huang D, Hu X, Qu J, Jin C, Xiang Y, Yang K, Zhou S, Chen X, Pan Y, Guo G, Zhang X (2011) Sentinel lymph node biopsy is unsuitable for routine practice in younger female patients with unilateral low-risk papillary thyroid carcinoma. BMC Cancer 11:386. doi:10.1186/1471-2407-11-386

    Article  PubMed Central  PubMed  Google Scholar 

  9. Ji YB, Lee KJ, Park YS, Hong SM, Paik SS, Tae K (2012) Clinical efficacy of sentinel lymph node biopsy using methylene blue dye in clinically node-negative papillary thyroid carcinoma. Ann Surg Oncol 19(6):1868–1873. doi:10.1245/s10434-011-2109-1

    Article  PubMed  Google Scholar 

  10. Perros P (2007) Guidelines for the management of thyroid cancer (trans: Group TCGU), 2nd edn. Royal College of Physicians, London

    Google Scholar 

  11. Kocjan G, Chandra A, Cross PA, Giles T, Johnson SJ, Stephenson TJ, Roughton M, Poller DN (2011) The interobserver reproducibility of thyroid fine-needle aspiration using the UK Royal College of Pathologists’ classification system. Am J Clin Pathol 135(6):852–859. doi:10.1309/AJCPZ33MVMGZKEWU

    Article  PubMed  Google Scholar 

  12. Barczynski M, Konturek A, Stopa M, Nowak W (2013) Prophylactic central neck dissection for papillary thyroid cancer. Br J Surg 100(3):410–418. doi:10.1002/bjs.8985

    Article  CAS  PubMed  Google Scholar 

  13. Lang BH, Ng SH, Lau L, Cowling B, Wong KP, Wan KY (2013) A systematic review and meta-analysis of prophylactic central neck dissection on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy. Thyroid. doi:10.1089/thy.2012.0608

    PubMed  Google Scholar 

  14. Moreno MA, Edeiken-Monroe BS, Siegel ER, Sherman SI, Clayman GL (2012) In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival. Thyroid 22(4):347–355. doi:10.1089/thy.2011.0121

    Article  PubMed  Google Scholar 

  15. National Institutes of Health (2010) Sentinel lymphnode in patients with papillary thyroid carcinoma and in patients with suspected thyroid neoplasia (SNTC). Available via Clinicaltrials.gov. http://clinicaltrials.gov/ct2/show/study/NCT01089335. Accessed 13/11/2011 2011

Download references

Authors’ contributions

Study conception and design: SPB, BJH TJS, JW and ZK; acquisition of data: SPB, JB, TJS, WLC, LS, ZK; analysis and interpretation of data: SPB, HYL, TJS, JW and ZK; drafting of the manuscript: SPB; critical revision of the manuscript: SPB, BJH, TJS, JW and ZK.

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. P. Balasubramanian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balasubramanian, S.P., Brignall, J., Lin, H.Y. et al. Sentinel node biopsy in papillary thyroid cancer—what is the potential?. Langenbecks Arch Surg 399, 245–251 (2014). https://doi.org/10.1007/s00423-014-1168-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-014-1168-8

Keywords

Navigation